Sudden Hearing Loss With a Red Flag on MRI
A 47-year-old man presents 5 days after waking with a profound left-sided hearing loss, continuous high-pitched tinnitus, and mild imbalance. He has no vertigo, no facial weakness, and no prior ear disease. Otoscopy is normal bilaterally. Audiometry shows left profound sensorineural hearing loss (PTA 95 dB) with 0% word recognition; the right ear is normal (PTA 12 dB). He has type 2 diabetes (HbA1c 8.1%) and hypertension. He was started on high-dose oral prednisone 60 mg daily by an urgent care clinician 3 days ago. MRI with contrast of the internal auditory canals is ordered and shows a 1.2 cm enhancing mass in the left internal auditory canal extending to the cerebellopontine angle, with a widened porus acusticus.
1. How do you reconcile the sudden hearing loss with the MRI finding, and what is your immediate management?
Read the worked answer
The MRI finding is consistent with a vestibular schwannoma (acoustic neuroma), but the acute presentation is still treated as sudden sensorineural hearing loss (SSNHL) - the tumor is a predisposing/associated factor, not a reason to withhold therapy.
Immediate management:
- Continue high-dose corticosteroids (oral prednisone 1 mg/kg/day, taper over 1–2 weeks) because treatment within the first 2 weeks offers the best chance of recovery; intratympanic dexamethasone can be added if oral therapy is contraindicated or response is poor.
- Do not stop steroids because of the tumor; SSNHL in the setting of a small vestibular schwannoma is treated identically to idiopathic SSNHL.
- Control comorbidities: optimize glucose (steroids will worsen HbA1c) and blood pressure; monitor for steroid-induced hyperglycemia.
- Counsel that recovery is variable and that the tumor is small and typically slow-growing.
- Arrange repeat audiometry in 2–4 weeks and surveillance MRI in 6 months to assess growth.
2. The patient's hearing does not recover. How do you counsel him about management of the vestibular schwannoma, and what factors favor observation versus intervention?
Read the worked answer
Counseling should be shared decision-making framed around tumor size, growth, hearing status, and patient goals.
Favor observation with serial MRI:
- Small (≤1.5 cm) intracanalicular/CPA tumor with no brainstem compression.
- Many vestibular schwannomas grow slowly or not at all; observation avoids treatment-related facial nerve and hearing risk.
- The left ear is already profoundly deaf, so hearing preservation is no longer a treatment goal on that side; the priority becomes preserving facial nerve function and avoiding brainstem compression.
Favor intervention (surgery or stereotactic radiosurgery):
- Documented growth on serial imaging, new facial weakness, brainstem compression, or intractable imbalance.
- Surgery (translabyrinthine or retrosigmoid) is reasonable for larger or growing tumors; stereotactic radiosurgery is an option for smaller tumors with documented growth, though it risks further hearing loss and is less useful when hearing is already gone.
Key counseling points: facial nerve risk increases with size; annual MRI for the first few years, then spaced out if stable; and the contralateral ear must be protected (avoid ototoxic drugs, noise).